The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
S100A4 in cancer progression and metastasis: A systematic review
Open accessAbstract
// Fei Fei 1, 2 , Jie Qu 1, 2 , Mingqing Zhang 3 , Yuwei Li 3 and Shiwu Zhang 2 1 Nankai University School of Medicine, Nankai University, Tianjin, 300071, P.R.China 2 Department of Pathology, Tianjin Union Medical Center, Tianjin, 300121, P.R. China 3 Department of Colorectal Surgery, Tianjin Union Medical Center, Tianjin, 300121, P.R. China Correspondence to: Shiwu Zhang, email: zhangshiwu666@aliyun.com Keywords: S100A4, metastasis, malignant tumor, epithelial-mesenchymal transition Received: April 11, 2017 Accepted: May 08, 2017 Published: May 19, 2017 ABSTRACT Metastasis is the leading cause of cancer-related death and directly associates with cancer progression, resistance to anticancer therapy, and poor patient survival. Current efforts focusing on the underlying molecular mechanisms of cancer metastasis attract a special attention to cancer researchers. The epithelial-mesenchymal transition is a complex of molecular program during embryogenesis, inflammation, tissue fibrosis, and cancer progression and metastasis. S100A4, an important member of S100 family proteins, functions to increase the tumor progression and metastasis. The molecular mechanisms of S100A4 involving in the progression and metastasis are diverse in various malignant tumors. Detection of S100A4 expression becomes a promising candidate biomarker in cancer early diagnosis and prediction of cancer metastasis and therefore, S100A4 may be a therapeutic target. This review summarized up to date advancement on the role of S100A4 in human cancer development, progression, and metastasis and the underlying molecular events and then strategies to target S100A4 expression experimentally.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The perivascular niche regulates breast tumour dormancy
Ghajar, C. M., Peinado, H., Mori, H., Matei, I. R., Evason, K. J., Brazier, H., Almeida, D., Koller, A., Hajjar, K. A., Stainier, D. Y. R., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2767 · Cited by 1,148 · cited 21×
“Several studies have indicated that S100A4 promotes tumor cell migratory phenotype and that the reduced S100A4 levels decrease tumor cell migration as well as inhibit tumor cell EMT [54].”
BackgroundInfluentialUpdate on Survival in Osteosarcoma
Anderson, M. E. (2016) · Orthopedic Clinics of North America · doi:10.1016/j.ocl.2015.08.022 · Cited by 560
Kidd, S., Spaeth, E., Watson, K., Burks, J., Lu, H., Klopp, A., Andreeff, M., & Marini, F. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030563 · Cited by 371
VEGF-A and Tenascin-C produced by S100A4 + stromal cells are important for metastatic colonization
O'Connell, J. T., Sugimoto, H., Cooke, V. G., MacDonald, B. A., Mehta, A. I., LeBleu, V. S., Dewar, R., Rocha, R. M., Brentani, R. R., Resnick, M. B., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109493108 · Cited by 348 · cited 1×
“S100A4 participates in the molecular signal-network of the tumor milieu that contributes to cancer metastasis through the modulation of both primary tumor and pre-metastatic niche [44, 45].”
Background
Cited by
Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target
Abdelfattah, N., Kumar, P., Wang, C., Leu, J.-S., Flynn, W. F., Gao, R., Baskin, D. S., Pichumani, K., Ijare, O. B., Wood, S. L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28372-y · Cited by 465
Single-cell lineage tracing of metastatic cancer reveals selection of hybrid EMT states
Simeonov, K. P., Byrns, C. N., Clark, M. L., Norgard, R. J., Martin, B., Stanger, B. Z., Shendure, J., McKenna, A., & Lengner, C. J. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.05.005 · Cited by 385
Role of S100 proteins in health and disease
Gonzalez, L. L., Garrie, K., & Turner, M. D. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118677 · Cited by 361
Rébé, C., & Ghiringhelli, F. (2020) · Cancers · doi:10.3390/cancers12071791 · Cited by 337
Alanazi, B., Munje, C. R., Rastogi, N., Williamson, A. J. K., Taylor, S., Hole, P. S., Hodges, M., Doyle, M., Baker, S., Gilkes, A. F., et al. (2020) · Leukemia · doi:10.1038/s41375-019-0596-4 · Cited by 64
Metadata
- Authors
- Fei, F., Qu, J., Zhang, M., Li, Y., & Zhang, S.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2017-05-19
- Volume
- 8
- Issue
- 42
- Pages
- 73219-73239
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2616193394
- Cited by
- 199
- References
- 4
- FWCI
- 1.45
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.